Stocktoria
MiniMed Group, Inc. MMED
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · IPO 2026-03-06
MiniMed Group, Inc. financials (annual, from 10-K)
Bars are annual figures from 2025 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 |
|---|---|---|
| Revenue | $3.1B | $2.7B |
| Gross profit | $1.7B | $1.5B |
| SG&A expense | $1.2B | $1.1B |
| Operating income | -$190.0M | -$146.0M |
| Income tax | $128.0M | $52.0M |
| Net income | -$333.0M | -$213.0M |
| EPS (diluted) | $-1.30 | $-0.84 |
| Operating cash flow | -$197.0M | $140.0M |
| Free cash flow | -$420.0M | -$53.0M |
| Cash & equivalents | $298.0M | $11.0M |
| Inventory | $341.0M | $311.0M |
| Total assets | $4.6B | $4.2B |
| Total liabilities | $1.0B | $871.0M |
| Shareholders' equity | $3.6B | $3.3B |
Growth · year-over-year · Revenue CAGR 14.3%
| Metric | FY2026 | FY2025 |
|---|---|---|
| Revenue growth | +14.3% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0002062583 · as of 2026-04-24. Facts from filings plus Stocktoria's own computed scores — not investment advice.